Literature DB >> 3813690

Vasodilator prostaglandins (PG) prevent renal damage after ischemia.

R P Kaufman, H Anner, L Kobzik, C R Valeri, D Shepro, H B Hechtman.   

Abstract

Thromboxane (Tx) synthase but not cyclo-oxygenase inhibitors prevent acute tubular necrosis (ATN) after renal ischemia, a phenomenon believed to be due to stimulation of the endogenous production of vasodilating prostaglandins (PG). This study directly tests that vasodilating PG protect against the consequences of renal ischemia. Anesthetized, 500-g rats had right nephrectomy and 45 minutes of left renal pedicle clamping or sham clamping. The rats were treated with intravenous (I.V.) saline 1.9 mL/h starting 40 minutes after clamping or sham clamping. All rats except the sham group (N = 8) were pretreated 1 hour before ischemia with ibuprofen (12 mg/kg) to prevent prostanoid synthesis. Beginning 5 minutes before clamp release, the rats were treated intravenously for 2 hours with: saline vehicle (N = 9), PGE1 400 ng/kg/min (N = 6), nitroprusside 4 micrograms/kg/min (N = 8), or dopamine 3 micrograms/kg/min (N = 11). After 24 hours, sham rat creatinine level was 0.5 mg/dL and weight of the left kidney was 86.5% of the previously removed right kidney. Compared with sham rats, ischemia and saline treatment resulted in a rise in creatinine level to 2.7 mg/dL (p less than 0.05) and a rise in kidney weight to 101.9% (p less than 0.05); PGE1 led to a creatinine level of 1.1 mg/dL, a value lower than that of the rats treated with saline (p less than 0.05), and a kidney weight of 92.0%, a value similar to that of sham rats; nitroprusside and dopamine led to a rise in creatinine levels to 3.2 mg/dL (p less than 0.05) and 2.3 mg/dL (p less than 0.05), respectively, as well as a rise in kidney weight to 108.0% (p less than 0.05) and 105.4% (p less than 0.05), respectively. Histologic examination showed ATN in rats treated with saline, nitroprusside, and dopamine, but not in rats treated with PGE1. These results indicate that PGE1 protects the cyclo-oxygenase-treated kidney against ischemia-induced ATN.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3813690      PMCID: PMC1492833          DOI: 10.1097/00000658-198702000-00015

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  13 in total

1.  Japanese and American children's perception of parents.

Authors:  M MATSUMOTO; H T SMITH
Journal:  J Genet Psychol       Date:  1961-03       Impact factor: 1.509

2.  Acute oliguric renal failure in man: evidence for preferential renal cortical ischemia.

Authors:  N K Hollenberg; M Epstein; S M Rosen; R I Basch; D E Oken; J P Merrill
Journal:  Medicine (Baltimore)       Date:  1968-11       Impact factor: 1.889

3.  Diuresis and improved renal hemodynamics produced by prostaglandin E1 in the dog with norepinephrine-induced acute renal failure.

Authors:  P S Moskowitz; M Korobkin; O N Rambo
Journal:  Invest Radiol       Date:  1975 Jul-Aug       Impact factor: 6.016

Review 4.  Renal ischemia: a new perspective.

Authors:  M Brezis; S Rosen; P Silva; F H Epstein
Journal:  Kidney Int       Date:  1984-10       Impact factor: 10.612

5.  Alteration of postischemic renal pathology by prostaglandin infusion.

Authors:  K F Casey; G W Machiedo; M J Lyons; G J Slotman; R T Novak
Journal:  J Surg Res       Date:  1980-07       Impact factor: 2.192

6.  Effect of prostaglandin E1 on renal hemodynamics, sodium and water excretion.

Authors:  H H Johnston; J P Herzog; D P Lauler
Journal:  Am J Physiol       Date:  1967-10

7.  Protective effect of prostaglandin E1 on ischemia-induced acute renal failure in dogs.

Authors:  M Tobimatsu; K Konomi; S Saito; T Tsumagari
Journal:  Surgery       Date:  1985-07       Impact factor: 3.982

8.  Effect of prostaglandin E2 on chloride transport across the rabbit thick ascending limb of Henle. Selective inhibitions of the medullary portion.

Authors:  J B Stokes
Journal:  J Clin Invest       Date:  1979-08       Impact factor: 14.808

9.  Polyene toxicity in renal medulla: injury mediated by transport activity.

Authors:  M Brezis; S Rosen; P Silva; K Spokes; F H Epstein
Journal:  Science       Date:  1984-04-06       Impact factor: 47.728

Review 10.  Arachidonic acid metabolism, prostaglandins and the kidney.

Authors:  D J Levenson; C E Simmons; B M Brenner
Journal:  Am J Med       Date:  1982-02       Impact factor: 4.965

View more
  7 in total

1.  Efficacy of prostaglandin I2 analog on liver grafts subjected to 30 minutes of warm ischemia.

Authors:  A Kishida; Y Kurumi; M Kodama
Journal:  Surg Today       Date:  1997       Impact factor: 2.549

2.  The UW solution for canine kidney preservation. Its specific effect on renal hemodynamics and microvasculature.

Authors:  Y Ueda; S Todo; O Imventarza; H Furukawa; A Oks; Y M Wu; S Oguma; T E Starzl
Journal:  Transplantation       Date:  1989-12       Impact factor: 4.939

Review 3.  Renal dysfunction associated with liver transplantation.

Authors:  R M Jindal; I Popescu
Journal:  Postgrad Med J       Date:  1995-09       Impact factor: 2.401

4.  Effects of a stable prostacyclin analog on experimental ischemic acute renal failure.

Authors:  M Tobimatsu; Y Ueda; S Saito; T Tsumagari; K Konomi
Journal:  Ann Surg       Date:  1988-07       Impact factor: 12.969

5.  The effects of prostacyclin on gastric intramucosal pH in patients with septic shock.

Authors:  P Radermacher; R Buhl; B Santak; M Klein; H W Kniemeyer; H Becker; J Tarnow
Journal:  Intensive Care Med       Date:  1995-05       Impact factor: 17.440

6.  Misoprostol hepatoprotection against ischemia-reperfusion-induced liver injury in the rat.

Authors:  S P Lim; F J Andrews; C Christophi; P E O'Brien
Journal:  Dig Dis Sci       Date:  1992-08       Impact factor: 3.199

7.  Vasodilating prostaglandins attenuate ischemic renal injury only if thromboxane is inhibited.

Authors:  J M Klausner; I S Paterson; L Kobzik; C Rodzen; C R Valeri; D Shepro; H B Hechtman
Journal:  Ann Surg       Date:  1989-02       Impact factor: 12.969

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.